Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.
about
DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in miceDissecting the Role of E2 Protein Domains in Alphavirus PathogenicityDevelopment of Neutralization Assay Using an eGFP Chikungunya VirusA neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from diseaseChikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.Development of Vaccines for Chikungunya Fever.Next generation sequencing of DNA-launched Chikungunya vaccine virus.A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.Characterization of chikungunya virus-like particles.Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.A chimeric vesiculo/alphavirus is an effective alphavirus vaccineChikungunya virus and prospects for a vaccine.A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.Chikungunya Virus Vaccines: Viral Vector-Based Approaches.Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice.Protocols for Developing Novel Chikungunya Virus DNA Vaccines.Early events in alphavirus replication determine the outcome of infection.New PARP gene with an anti-alphavirus functionNovel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multi-valent, single dose protection against lethal alphavirus challenge.Vaccine and Therapeutic Options To Control Chikungunya Virus.Cellular and Molecular Immune Response to Chikungunya Virus Infection
P2860
Q24701765-E20AFE42-4889-4B15-8AD2-62780F0FECDFQ26314381-C9C2C4DF-BCD7-4A01-A5E5-54169C2840B5Q26314416-C7BC3259-390F-4FCA-A5B9-0E6384357659Q28533408-D6608C15-517F-4FA8-A355-846C3305E5FEQ30235512-C08B68B5-C84E-4A16-A9FB-43A194CA0D6DQ30240191-219179C4-952E-4A70-A9B5-AA64B703355FQ30384231-1DE0E83A-0172-4778-A5F3-DF6BD788DE5CQ33945612-B442F5AB-B34D-416C-BB2E-3C8A4336422AQ34268026-8D307EAE-F30C-4CA7-A184-2DDC23E6E9F0Q34992691-012DC114-7A48-43D1-8658-7AC275E6FC22Q35238179-3CF1A386-844F-4D5C-B24D-475B1B836951Q35581782-8AA9A48B-673F-4E62-AC27-6EC7287C64FCQ36506753-2F0D96E3-5A19-4DF6-A1CA-25CA8BFE74A5Q36582816-70133F44-07C7-4A5C-BBE4-A64659D69A93Q37643733-7833FC8A-A8A7-4934-AF8E-CF1500B76D51Q39128566-A2233780-5D20-4BEA-BE13-C17A7B45FBB6Q39172123-EB6EA761-C764-4FA7-95B2-4C93D1989024Q40656550-0598769D-AD5D-41AF-8E0F-E86E312A36E6Q42152799-625C4EFF-1841-4ACF-8F19-3ECC820B2AC8Q42280877-FFBF0063-B5CE-4D9E-BE50-A66CFC23BD6FQ45324058-26256BDE-7CA4-471A-A927-54DA73C3E040Q47566099-35D00FF9-8553-41AF-9F15-13F0AD4D0128Q58575620-69781CB2-0B15-45F3-A8B0-05206014EBAC
P2860
Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chimeric Chikungunya viruses a ...... a protective immune response.
@ast
Chimeric Chikungunya viruses a ...... a protective immune response.
@en
type
label
Chimeric Chikungunya viruses a ...... a protective immune response.
@ast
Chimeric Chikungunya viruses a ...... a protective immune response.
@en
prefLabel
Chimeric Chikungunya viruses a ...... a protective immune response.
@ast
Chimeric Chikungunya viruses a ...... a protective immune response.
@en
P2860
P50
P356
P1433
P1476
Chimeric Chikungunya viruses a ...... a protective immune response.
@en
P2093
P2860
P304
P356
10.1128/JVI.00844-11
P407
P5008
P577
2011-06-22T00:00:00Z